CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
NEWARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with more...
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Advaxis Stockholders Vote “FOR” Proposed Merger with Biosight
Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposals MONMOUTH JUNCTION, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and more...
Abeona Therapeutics Announces Support of EB Research Partnership’s Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa
NEW YORK and CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced its sponsorship of the second annual Venture Into Cures , more...
Arena Minerals Provides Update on Astra Exploration Qualifying Transaction
TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) — Arena Minerals Inc. (“Arena” or the “Company”) (TSX-V: AN) is pleased to provide an update on the proposed qualifying transaction (the “QT”) between Momentous Capital Corp. (TSX-V: MCC.P) more...
RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results
RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results PR Newswire Strategic investment of US$150 million by The Hawthorne Collective highlights quarter Cash balance of $400 million available to launch U.S. platform Discussions continue more...
Matinas BioPharma to Participate in 33rd Annual Piper Sandler Virtual Healthcare Conference
BEDMINSTER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) platform delivery more...
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update PR Newswire – Positive results from pharmacoeconomic cost effectiveness study of Motixafortide in stem cell mobilization support its use as standard of care in more...
TILT Holdings Approved to Begin Adult-Use Cannabis Retail Operations at its Brockton, Massachusetts Dispensary November 22, 2021
Commonwealth Alternative Care Brockton to host celebration of adult-use on December 4, 2021 PHOENIX, Nov. 18, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) ( NEO: TILT ) ( OTCQX: TLLTF ), more...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2021
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2021 PR Newswire VANCOUVER, Canada and HOUSTON, Texas , Nov. 18, 2021 /PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or more...
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative – Pfizer invests $15 million in Cardiff Oncology common shares – Adam Schayowitz, Ph.D., MBA, Vice President, Medicine Team Group more...